stars 1 stars 2 stars 3

We are a strategic advisory and equity investment firm with decades of experience in preclinical drug development. Our extensive knowledge base covers all aspects related to advancing early stage drug candidates toward human clinical testing such as drug manufacturing, drug product formulation, analytical/bioanalytical methods development and animal safety, toxicology, pharmacology, immunology and pharmacokinetic testing. We leverage our expertise by combining it with a wide range of preclinical services offered by our CRO affiliate, Calvert Laboratories in addition to trusted subcontractors to design and execute customized drug development partnership programs with preclinical stage biopharmaceutical companies.

Calvert Research Questions

The Calvert Research annual revenue was $5.2 million in 2026.

The NAICS codes for Calvert Research are [5231, 52, 523, 52311, 523110].

The SIC codes for Calvert Research are [87, 62].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users